Search
for
Sort by
Research 30 of 1000+
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Efficacy of Barictinib As Compared to Conventional Therapy as a Treatment for Alopecia Areata
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Citrullination at the Inflammatory Skin Barrier
- JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment
- JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment
- Baricitinib for alopecia areata
- Hair today, gone tomorrow
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Combination Treatment with Methotrexate for Severe Alopecia Areata
- 700 Oncostatin M is upstream of JAK-STAT signaling during the murine hair cycle
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Treatment of severe alopecia areata with baricitinib
- 570 Targeting JAK/STAT and Wnt/b-catenin pathways and 5a-reductase activity to develop an effective anti-hair loss product
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis
- The Role of Janus Kinase Inhibitors in Dermatology
- Evidence for the off-label use of tofacitinib in alopecia areata
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Alopecia universalis treated with simvastatin/ezetimibe, minoxidil, and prednisolone in a 6‐year‐old girl
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth